Search results for "Bullous"

showing 10 items of 12 documents

Retrospective Analysis of Checkpoint Inhibitor Therapy-Associated Cases of Bullous Pemphigoid From Six German Dermatology Centers

2021

Immune-related adverse events (irAEs) are a class-effect of checkpoint inhibitors (CIs). The development of a Bullous pemphigoid (BP)-like blistering disease, driven by autoantibodies against the hemidesmosomal protein BP180, is a potentially serious irAE whose incidence seems to be increasing. We therefore set out to characterize the clinical and (immuno)histopathological features and treatment responses of cases of BP which developed during or after CI therapy collated in six German tertiary referral centers between 2014 and 2018. We identified twelve cases of BP which emerged during and/or after CI therapy. The time interval between the initiation of CI therapy and the diagnosis of BP wa…

0301 basic medicineMalelcsh:Immunologic diseases. Allergymedicine.medical_specialtyPD-1 - PD-L1 axisautoantibodiesImmune checkpoint inhibitorsImmunologypemphigoid diseaseIpilimumabPembrolizumabDermatology030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicineAntineoplastic Agents ImmunologicalAdrenal Cortex HormonesInternal medicineGermanyNeoplasmsPemphigoid BullousmedicineHumansImmunology and AllergyipilimumabAdverse effectImmune Checkpoint InhibitorsAgedRetrospective StudiesOriginal ResearchAged 80 and overnivolumabbusiness.industryIncidence (epidemiology)autoimmunityAutoantibodyMiddle Agedmedicine.disease030104 developmental biologyFemaleBullous pemphigoidpembrolizumabNivolumabbusinesslcsh:RC581-607checkpoint inhibitorsmedicine.drugFrontiers in Immunology
researchProduct

Evolution of Corneal Graft Survival Over a 30-Year Period and Comparison of Surgical Techniques: A Cohort Study.

2015

Purpose To compare graft survival between 3 10-year periods and according to surgical techniques performed in the last years. Design Cohort study. Methods setting: Regional center (Besancon University Hospital, France). patients: All 1132 patients operated on between 1983 and 2014. Graft and patient baseline characteristics, risk factors for failure, surgical procedures, and postoperative corneal status were collected. main outcome measures: Five-year survival rate in the whole cohort; 1-year and 3-year survival rates, respectively, among 88 patients with endothelial dystrophy (ED) or postoperative bullous keratopathy (PBK) operated on using endothelial lamellar keratoplasty (ELK) or penetr…

AdultGraft RejectionMalemedicine.medical_specialtyKeratoconusTime FactorsCorneal graftVisual AcuityCorneal DiseasesCohort StudiesCorneal Transplantation03 medical and health sciences0302 clinical medicineRisk FactorsMedicineHumansProspective StudiesSurvival rateAgedbusiness.industryHazard ratioGraft SurvivalSurgical proceduresMiddle Agedmedicine.diseaseSurgeryOphthalmologyTreatment OutcomeCohort030221 ophthalmology & optometryBullous keratopathyFemaleFrancebusiness030217 neurology & neurosurgeryCohort studyFollow-Up StudiesAmerican journal of ophthalmology
researchProduct

CLINICAL AND LABORATORY FINDINGS OF BOUTONNEUSE FEVER IN SICILIAN CHILDREN

1998

The spectrum of signs and symptoms of 645 consecutive children diagnosed from 1984 to 1996 with boutonneuse fever (BF), a mild rickettsial disease caused by Rickettsia conorii endemic in the Mediterranean basin, are reported. The major clinical features were fever (97.2%), exanthema (96.1%) and “tache noire” (71.8%). The large series examined permitted the authors to observe some rare or disregarded clinical features of the disease: cases with papulovesicular exanthema, reported previously only in adults who had been infected by R. conorii in Africa; and cases in which the only symptom was an isolated lymphadenopathy. Conclusion R. conorii infection should be considered in patients with lym…

Malemedicine.medical_specialtyAdolescentFluorescent Antibody Techniqueboutonneuse feverSerologymedicineHumansRickettsiaChildDirect fluorescent antibodyLymphatic DiseasesbiologySkin Diseases Vesiculobullousbusiness.industryInfantTache noir de la sclerotiqueExanthemamedicine.diseasebiology.organism_classificationDermatologyBoutonneuse feverRickettsiosisRickettsiaItalyChild PreschoolPediatrics Perinatology and Child HealthImmunologyFemalebusinessRickettsia conoriiRickettsiales
researchProduct

Number 1Epithelial biology

2005

The oral mucous membrane has features similar to skin but also differs in several ways. This paper reviews the aspects of epithelial biology necessary for an understanding of the vesiculoerosive disorders.

Pathologymedicine.medical_specialtybiologyAdenomatous polyposis coliOral mucous membranemacromolecular substancesEpitheliummedicine.anatomical_structureOtorhinolaryngologyGSK-3Bullous Pemphigoid Antigenmedicinebiology.proteinCancer researchGeneral DentistryOral Diseases
researchProduct

Systemic lupus erythematosus and bullous pemphigoid with dramatic response to dapsone

2017

Patient: Female, 11 Final Diagnosis: Bullous pemphigoid in systemic lupus erythematosus Symptoms: Bullous lupus • photosensitive rash • synovitis Medication:— Clinical Procedure: Pharmacological treatment Specialty: Rheumatology Objective: Unusual clinical course Background: Bullous pemphigoid is an autoimmune blistering disease, with relapses, isolated or associated with other autoimmune diseases such as systemic lupus erythematosus (SLE). Joint manifestations rapidly respond to small or moderate doses of corticosteroids, whereas skin manifestations usually respond to antimalarial drugs. Case Report: We describe the clinical case of an 11-year-old girl with SLE. She showed bullous skin les…

Pemphigoidmedicine.medical_specialtyAntimalarials; Child; Dapsone; Female; Humans; Lupus Erythematosus Systemic; Pemphigoid BullousMild proteinuriaArthritisDapsoneAntimalarials030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicineSettore MED/38 - Pediatria Generale E SpecialisticaPrednisoneimmune system diseasesPemphigoid BullousmedicineHumansChildskin and connective tissue diseases030203 arthritis & rheumatologyLupus erythematosusintegumentary systembusiness.industryMedicine (all)Dapsone; Lupus erythematosus systemic; Pemphigoid bullous; Medicine (all)ArticlesGeneral Medicinemedicine.diseasePemphigoid bullouDermatologyeye diseasesLupus erythematosus systemicFemaleBullous pemphigoidsense organsbusinessDapsonemedicine.drugPediatric population
researchProduct

Diagnostics of autoimmune bullous diseases in German dermatology departments

2012

Summary Background: No consistent data are available on the currently employed diagnostic tools for autoimmune bullous diseases in Germany. The aim of this survey was to describe currently performed diagnostic methods for bullous autoimmune diseases in German dermatology departments. Methods: A standardized questionnaire evaluated the available diagnostic methods i. e. direct immunofluorescence microscopy (IFM), indirect IFM, commercial ELISA systems, and non-commercial serological tests as well as the number of samples per year in all 34 university and 39 non-university dermatology departments. Results: The overall return rate was 89 %, 100 % and 79 % for the university and non-university …

Pemphigoidmedicine.medical_specialtyDiagnostic methodsbusiness.industryDiagnostic testDermatologymedicine.diseaseDiagnostic toolsDermatologyhumanities3. Good healthSerology030207 dermatology & venereal diseases03 medical and health sciencesPemphigus0302 clinical medicine030220 oncology & carcinogenesisMedicineBullous pemphigoidbusinessDirect fluorescent antibodyJDDG: Journal der Deutschen Dermatologischen Gesellschaft
researchProduct

Queratitis bacteriana por Moraxella nonliquefaciens

2020

Moraxella keratitis can lead to important complications. Moraxella nonliquefaciens(M. nonliquefaciens) has the worst prognosis. Only three cases of corneal infections due to M. nonliquefaciens have been published. The case is presented of a 79-year-old man with bullous keratopathy, recently affected with severe infectious keratitis. Dense, deep, and central stromal infiltrates and hyphaema were detected. After the identification of M. nonliquefaciens in the culture, and given the progression of the condition, the initial empirical treatment was modified to topical ciprofloxacin and ceftazidime in accordance with the antibiogram, combining oral ciprofloxacin and amoxicillin-clavulanate. Afte…

medicine.medical_specialtyCorneal Infectionbiologybusiness.industryInfectious Keratitismedicine.diseasebiology.organism_classificationDermatologyMoraxella nonliquefaciensKeratitisCiprofloxacinOphthalmologyLeucomamedicineBullous keratopathybusinessMoraxellamedicine.drugArchivos de la Sociedad Española de Oftalmología
researchProduct

Angina bullosa hemorrhagica, an uncommon oral disorder. Report of 4 cases

2020

Angina bullosa hemorrhagica (ABH) is a rare oral disorder characterized by blood-filled bullous lesions in the oral cavity and the oropharynx in the absence of an underlying systemic, haematological or mucocutaneous condition. The presentation of the lesions is acute and located on the lining mucosa, mainly on the soft palate. Often, these lesions are single and rupture easily leaving an ulcerated area. In this study, we present 4 ABH cases in 3 women and 1 man and we discuss the main clinicopathological characteristics. The characteristics of this disorder are important to recognize in order to differentiate the lesions from other oral bullous conditions of the oral cavity such as mucocuta…

medicine.medical_specialtyOral Medicine and PathologyAngina bullosa hemorrhagicaSoft palateintegumentary systembusiness.industryMucocutaneous zoneCase ReportMouth -- DiseasesOral cavity:CIENCIAS MÉDICAS [UNESCO]DermatologyBullous lesionsstomatognathic diseasesmedicine.anatomical_structureUNESCO::CIENCIAS MÉDICASmedicineotorhinolaryngologic diseasesOral disorderBlistersPresentation (obstetrics)businessskin and connective tissue diseasesGeneral DentistryCoagulation DisorderJournal of Clinical and Experimental Dentistry
researchProduct

Symmetrical pustulosis unfolds over systemic lupus erythematosus.

2021

medicine.medical_specialtyRheumatologySkin Diseases VesiculobullousSystemic lupusbusiness.industrymedicineHumansLupus Erythematosus SystemicPharmacology (medical)medicine.symptomPustulosisbusinessDermatologyRheumatology (Oxford, England)
researchProduct

Descemet Membrane Endothelial Keratoplasty for Corneal Decompensation Secondary to Phakic Intraocular Lenses

2019

Purpose. To describe the surgical technique and clinical outcomes of bilensectomy (pIOL explant and phacoemulsification), followed by DMEK performed for bullous keratopathy secondary to pIOL.Methods. Seven eyes of seven patients, who developed corneal decompensation after pIOL implantation, underwent bilensectomy followed by DMEK in a two-step procedure. Main outcome measures included uncorrected visual acuity (UCVA) and best-corrected visual acuity (BCVA), refraction, endothelial cell density (ECD) at 1, 3, 6, and 12 months, and intraoperative and postoperative complications.Results. DMEK was performed at a mean time of 9.83 ± 8.23 months after bilensectomy. BCVA (log MAR) improved in all …

medicine.medical_specialtyVisual acuityDescemet membraneCorneal Decompensationgenetic structuresArticle Subjectbusiness.industrymedicine.medical_treatmentUncorrected visual acuityPhacoemulsificationPhakic intraocular lenseye diseasesOphthalmologylcsh:Ophthalmologylcsh:RE1-994OphthalmologyBullous keratopathymedicinePrimary graft failuremedicine.symptombusinessResearch ArticleJournal of Ophthalmology
researchProduct